The European Association of Urology (EAU) has published criteria for low‐, intermediate‐, and high‐risk groups for BCR of PCa based on preoperative PSA, Gleason score, and clinical stage, and has reported that the BCR risk grouping reached an independent predictor status for metastasis progression (hazard ratio [HR], 3.46; p < 0.001) and PCa mortality (HR, 5.12; p < 0.001).11 The gene discussed is BCR; the disease is posterior cortical atrophy.